Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

1(100.0%)

1Total

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT00930319Completed

Effectiveness and Safety of Firmagon®

Role: collaborator

NCT04927676Unknown

Hormones in Hypogonadotropic Hypogonadism

Role: collaborator

NCT01365351Completed

Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

Role: collaborator

NCT01517607Completed

Mesalazine (PENTASA®) in Ulcerative Colitis

Role: collaborator

NCT01225835Phase 4Completed

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)

Role: collaborator

NCT01368913Completed

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

Role: collaborator

NCT01220453Completed

Compliance and Efficacy in the Use of PICOPREP®

Role: collaborator

NCT01148433Completed

Quality of Life With TESTIM®

Role: collaborator

NCT01363453Completed

User Surveillance in Ulcerative Colitis

Role: collaborator

All 9 trials loaded